aspirin has been researched along with Proteinuria in 72 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Proteinuria: The presence of proteins in the urine, an indicator of KIDNEY DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "There was no significant difference in urinary proteinuria after 6 weeks of treatment with placebo or celecoxib (proteinuria ratio, celecoxib versus placebo, 1." | 9.12 | A randomized trial of a 6-week course of celecoxib on proteinuria in diabetic kidney disease. ( Chen, H; Clyne, S; Han, E; Harris, R; Lehrich, R; Lewis, J; Middleton, J; Rodby, R; Schulman, G; Shyr, Y; Sika, M; Sinsakul, M, 2007) |
| "The efficacy of low-dose aspirin in preventing fetal growth retardation was tested in a randomised, placebo-controlled, double-blind trial." | 9.07 | Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial. ( Bazin, B; Beaufils, M; Breart, G; Capitant, C; Paris, J; Uzan, S, 1991) |
| " This study investigates the influence of aspirin plus dipyridamole on proteinuria and renal function in nephrotic MPGN patients with moderately reduced glomerular filtration rate." | 9.07 | Effect of aspirin and dipyridamole on proteinuria in idiopathic membranoproliferative glomerulonephritis: a multicentre prospective clinical trial. Collaborative Glomerulonephritis Therapy Study Group (CGTS) ( Böhler, J; Braun, N; Grupp, C; Heering, P; Schollmeyer, P; Zäuner, I, 1994) |
| "Our results demonstrated that the combination of quercetin and aspirin exerted significantly stronger effects than aspirin alone on decreasing systolic blood pressure and proteinuria, reducing pro-inflammatory cytokine production, and inhibiting M1-type decidual macrophages polarization in an LPS-induced rat model of preeclampsia." | 8.31 | Natural Flavonoid Quercetin Enhances the Anti-inflammatory Effects of Aspirin in a Preeclampsia-like Rat Model Induced by Lipopolysaccharide. ( Chen, D; Ding, J; Liu, A; Yang, S, 2023) |
| "Treatment with curcumin and aspirin combination significantly reduced the systolic blood pressure and proteinuria in the PE rats." | 8.31 | Combining curcumin and aspirin ameliorates preeclampsia-like symptoms by inhibiting the placental TLR4/NF-κB signaling pathway in rats. ( Feng, Y; Hou, X; Ju, Y; Wang, Y; Yang, M; Yang, Y; Zhang, X; Zhu, X, 2023) |
| "Aspirin is a common drug for the treatment of pre-eclampsia." | 8.12 | Quercetin Supplement to Aspirin Attenuates Lipopolysaccharide-Induced Pre-eclampsia-Like Impairments in Rats Through the NLRP3 Inflammasome. ( Chen, D; Ding, J; Song, L; Yang, S; Zhang, J; Zhang, Y, 2022) |
| "A sudden hearing loss in a woman on aspirin has uncovered a frequently neglected toxicological parameter." | 7.75 | Hearing loss in a woman on aspirin: the silent pharmacokinetic parameter. ( Koren, G, 2009) |
| "1 The effects of aspirin, prednisolone, and indomethacin on nephrotoxic serum nephritis in rats was studied." | 7.66 | Effects of aspirin, prednisolone and indomethacin on nephrotoxic serum nephritis in the rat. ( Kurokawa, H; Sakamoto, K, 1982) |
| " In nephrotoxic serum nephritis, seromucoid levels were correlated with the proteinuria of the autologous phase and were found to be a good complementary criterion for the analysis of the efficiency of pyridinol carbamate, colchicine, iysine acetylsalicylate, and L-asparaginase." | 7.65 | Biochemical criteria for the evaluation of drug efficiency on adjuvant arthritis and nephrotoxic serum nephritis in the rat: studies with phenylbutazone, L-Asparaginase, colchicine, lysine acetylsalicylate, and pyridinol carbamate. ( Engler, R; Feret, J; Grochulski, A; Jayle, MF; Lagrue, G; Moisy, M; Peyroux, J; Sternberg, M, 1975) |
| "Treatment with indomethacin, aspirin, or prednisone has been shown to reduce urinary fibrin/fibrinogen degradation products (F." | 6.64 | Modification by drugs of urinary fibrin/fibrinogen degradation products in glomerulonephritis. ( Cash, JD; Clarkson, AR; MacDonald, MK; Robson, JS, 1972) |
| "Quercetin is a bioflavonoid which has anti-oxidant and reno-protective abilities." | 5.51 | Ameliorative effects of pre-eclampsia by quercetin supplement to aspirin in a rat model induced by L-NAME. ( Ma, Y; Shi, X; Song, L; Yang, S; Zhao, N, 2019) |
| "They found that in the course of treatment proteinuria did not change and glomerular filtration declined insignificantly." | 5.28 | [The effect of acetylsalicylic acid and dipyridamole on glomerular filtration and proteinuria in chronic glomerulonephritis]. ( Jáchymová, M; Knotková, V; Nĕmecek, K; Petrů, I, 1990) |
| " The following were consistently recommended: (1) automated blood pressure measurement with devices validated for pregnancy and preeclampsia, reflecting increasing recognition of the prevalence of white-coat hypertension and the potential usefulness of home blood pressure monitoring; (2) use of dipstick proteinuria testing for screening followed by quantitative testing by urinary protein-to-creatinine ratio or 24-hour urine collection; (3) key definitions and most aspects of classification, including a broad definition of preeclampsia (which includes proteinuria and maternal end-organ dysfunction, including headache and visual symptoms and laboratory abnormalities of platelets, creatinine, or liver enzymes) and a recognition that it can worsen after delivery; (4) preeclampsia prevention with aspirin; (5) treatment of severe hypertension, most commonly with intravenous labetalol, oral nifedipine, or intravenous hydralazine; (6) treatment for nonsevere hypertension when undertaken, with oral labetalol (in particular), methyldopa, or nifedipine, with recommendations against the use of renin-angiotensin-aldosterone inhibitors; (7) magnesium sulfate for eclampsia treatment and prevention among women with "severe" preeclampsia; (8) antenatal corticosteroids for preterm birth but not hemolysis, elevated liver enzymes, and low platelet count syndrome; (9) delivery at term for preeclampsia; (10) a focus on usual labor and delivery care but avoidance of ergometrine; and (11) an appreciation that long-term health complications are increased in incidence, mandating lifestyle change and risk factor modification." | 5.22 | Guidelines-similarities and dissimilarities: a systematic review of international clinical practice guidelines for pregnancy hypertension. ( Gillon, TE; Magee, LA; Pels, A; Scott, G; von Dadelszen, P, 2022) |
| " During the randomized phase, there were small but significant differences between the groups in BP, proteinuria, LDL cholesterol, and use of aspirin, statins, active vitamin D, and antihypertensive medications, in favor of the intervention group." | 5.19 | Nurse practitioner care improves renal outcome in patients with CKD. ( Blankestijn, PJ; Bots, ML; Kaasjager, KA; Ligtenberg, G; Peeters, MJ; Sijpkens, YW; Sluiter, HE; Ten Dam, MA; van Buren, M; van de Ven, PJ; van den Brand, JA; van Zuilen, AD; Vervoort, G; Vleming, LJ; Wetzels, JF, 2014) |
| "There was no significant difference in urinary proteinuria after 6 weeks of treatment with placebo or celecoxib (proteinuria ratio, celecoxib versus placebo, 1." | 5.12 | A randomized trial of a 6-week course of celecoxib on proteinuria in diabetic kidney disease. ( Chen, H; Clyne, S; Han, E; Harris, R; Lehrich, R; Lewis, J; Middleton, J; Rodby, R; Schulman, G; Shyr, Y; Sika, M; Sinsakul, M, 2007) |
| "This was a prospective observation of pregnancy outcomes among 462 women with pregestational diabetes mellitus (White classes B-F) and singleton pregnancies who were enrolled in a multicenter trial to compare low-dose aspirin with placebo for preeclampsia prevention." | 5.09 | Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. ( Caritis, S; Dombrowski, M; Hauth, J; Klebanoff, M; Landon, M; Lindheimer, M; MacPherson, C; McNellis, D; Meis, P; Miodovnik, M; Paul, R; Roberts, J; Sibai, BM; Thurnau, G; VanDorsten, JP, 2000) |
| " This study investigates the influence of aspirin plus dipyridamole on proteinuria and renal function in nephrotic MPGN patients with moderately reduced glomerular filtration rate." | 5.07 | Effect of aspirin and dipyridamole on proteinuria in idiopathic membranoproliferative glomerulonephritis: a multicentre prospective clinical trial. Collaborative Glomerulonephritis Therapy Study Group (CGTS) ( Böhler, J; Braun, N; Grupp, C; Heering, P; Schollmeyer, P; Zäuner, I, 1994) |
| "The efficacy of low-dose aspirin in preventing fetal growth retardation was tested in a randomised, placebo-controlled, double-blind trial." | 5.07 | Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial. ( Bazin, B; Beaufils, M; Breart, G; Capitant, C; Paris, J; Uzan, S, 1991) |
| "The present review focuses on the roles of thromboxane A2 (TxA2) in arterial thrombosis, atherogenesis, vascular stent-related ischemic events and renal proteinuria." | 4.85 | Effect of pharmaceutical interventions targeting thromboxane receptors and thromboxane synthase in cardiovascular and renal diseases. ( Alberts, P; Bounameaux, H; Fontana, P; Mann, J; Sakariassen, KS; Sorensen, AS, 2009) |
| "Our results demonstrated that the combination of quercetin and aspirin exerted significantly stronger effects than aspirin alone on decreasing systolic blood pressure and proteinuria, reducing pro-inflammatory cytokine production, and inhibiting M1-type decidual macrophages polarization in an LPS-induced rat model of preeclampsia." | 4.31 | Natural Flavonoid Quercetin Enhances the Anti-inflammatory Effects of Aspirin in a Preeclampsia-like Rat Model Induced by Lipopolysaccharide. ( Chen, D; Ding, J; Liu, A; Yang, S, 2023) |
| "Treatment with curcumin and aspirin combination significantly reduced the systolic blood pressure and proteinuria in the PE rats." | 4.31 | Combining curcumin and aspirin ameliorates preeclampsia-like symptoms by inhibiting the placental TLR4/NF-κB signaling pathway in rats. ( Feng, Y; Hou, X; Ju, Y; Wang, Y; Yang, M; Yang, Y; Zhang, X; Zhu, X, 2023) |
| "Aspirin is a common drug for the treatment of pre-eclampsia." | 4.12 | Quercetin Supplement to Aspirin Attenuates Lipopolysaccharide-Induced Pre-eclampsia-Like Impairments in Rats Through the NLRP3 Inflammasome. ( Chen, D; Ding, J; Song, L; Yang, S; Zhang, J; Zhang, Y, 2022) |
| " Therapeutic strategies using lipid mediators, such as aspirin-triggered resolvin D1 (ATRvD1), can contribute to the resolution of acute and chronic inflammation." | 4.02 | ATRvD1 Attenuates Renal Tubulointerstitial Injury Induced by Albumin Overload in Sepsis-Surviving Mice. ( Almeida-Souza, F; Benjamim, CF; Calabrese, KS; Calcia, TBB; Caruso-Neves, C; Guilherme, RF; Lemos, FS; Neves, JS; Silva, CP; Silva, JBNF, 2021) |
| "A sudden hearing loss in a woman on aspirin has uncovered a frequently neglected toxicological parameter." | 3.75 | Hearing loss in a woman on aspirin: the silent pharmacokinetic parameter. ( Koren, G, 2009) |
| " This study investigates the effect of acetylsalicylic acid (ASA) combined with dipyridamole on proteinuria and renal function in nephrotic MPGN patients with normal/moderately reduced glomerular filtration rate (GFR)." | 3.71 | Effect of acetylsalicylic acid and dipyridamole in primary membranoproliferative glomerulonephritis type I. ( Baştürk, T; Harmankaya, O; Karabiber, N; Obek, A; Oztürk, Y, 2001) |
| "1 The effects of aspirin, prednisolone, and indomethacin on nephrotoxic serum nephritis in rats was studied." | 3.66 | Effects of aspirin, prednisolone and indomethacin on nephrotoxic serum nephritis in the rat. ( Kurokawa, H; Sakamoto, K, 1982) |
| " In nephrotoxic serum nephritis, seromucoid levels were correlated with the proteinuria of the autologous phase and were found to be a good complementary criterion for the analysis of the efficiency of pyridinol carbamate, colchicine, iysine acetylsalicylate, and L-asparaginase." | 3.65 | Biochemical criteria for the evaluation of drug efficiency on adjuvant arthritis and nephrotoxic serum nephritis in the rat: studies with phenylbutazone, L-Asparaginase, colchicine, lysine acetylsalicylate, and pyridinol carbamate. ( Engler, R; Feret, J; Grochulski, A; Jayle, MF; Lagrue, G; Moisy, M; Peyroux, J; Sternberg, M, 1975) |
| " There was no lysozymuria with severe uraemic heart failure, aspirin and paracetamol poisoning, or severe jaundice, nor in two cases of acute glomerulonephritis." | 3.65 | Lysozymuria and acute disorders of renal function. ( De Silva, KL; Harrison, JF; Parker, RW, 1973) |
| "Renal function was studied in 17 patients with rheumatoid arthritis who had each consumed between 5 and 20 kg of aspirin." | 3.65 | Aspirin and analgesic nephropathy. ( Craft, AW; Kerr, DN; Macklon, AF; Thompson, M, 1974) |
| "Proteinuria was independently associated with the incidence of primary cardiovascular events in diabetic patients." | 2.94 | Proteinuria is independently associated with the incidence of primary cardiovascular events in diabetic patients. ( Jinnouchi, H; Masuda, I; Matsumoto, C; Morimoto, T; Nakayama, M; Ogawa, H; Okada, S; Saito, Y; Soejima, H; Waki, M, 2020) |
| "Treatment with indomethacin, aspirin, or prednisone has been shown to reduce urinary fibrin/fibrinogen degradation products (F." | 2.64 | Modification by drugs of urinary fibrin/fibrinogen degradation products in glomerulonephritis. ( Cash, JD; Clarkson, AR; MacDonald, MK; Robson, JS, 1972) |
| " Avoidance of nephrotoxic and teratogenic medications is necessary, and renal dosing of commonly used medications must also be considered." | 2.61 | Chronic Kidney Disease and Pregnancy. ( Hladunewich, MA; Hui, D, 2019) |
| "Quercetin is a bioflavonoid which has anti-oxidant and reno-protective abilities." | 1.51 | Ameliorative effects of pre-eclampsia by quercetin supplement to aspirin in a rat model induced by L-NAME. ( Ma, Y; Shi, X; Song, L; Yang, S; Zhao, N, 2019) |
| "We enrolled 35 patients with MPGN type 1 who had a normal creatinine clearance at the time of their first renal biopsy and divided them into 2 groups based on clinical status at the time of their most recent examination: 12 patients with normal urine test results and 12 patients with minor urinary abnormalities at the latest observation (group 1) and 7 patients with persistent nephropathy and 4 patients with renal insufficiency (group 2)." | 1.33 | Myeloid-related protein 8 expression on macrophages is a useful prognostic marker for renal dysfunction in children with MPGN type 1. ( Hosoya, M; Isome, M; Kawasaki, Y; Suzuki, H; Takahashi, A; Tanji, M, 2005) |
| "Treatment with dipyridamole alone or with aspirin produced significant inhibition of platelet aggregation and a fall in 24-h protein excretion; the latter amounted to 54% with dipyridamole alone and 56% with dipyridamole plus aspirin (NS)." | 1.28 | Effect of dipyridamole with or without aspirin on urine protein excretion in patients with membranous glomerulonephritis. ( Cámara, S; De La Cruz, JP; Frutos, MA; Sánchez De La Cuesta, F, 1992) |
| "They found that in the course of treatment proteinuria did not change and glomerular filtration declined insignificantly." | 1.28 | [The effect of acetylsalicylic acid and dipyridamole on glomerular filtration and proteinuria in chronic glomerulonephritis]. ( Jáchymová, M; Knotková, V; Nĕmecek, K; Petrů, I, 1990) |
| "In patients with preeclampsia the renal excretion of beta 2-microglobulin allows to differentiate between a primary preeclampsia and a preeclampsia superimposed upon chronic pyelonephritis." | 1.26 | Beta 2-microglobulin and other proteins as parameter for tubular function. ( Jaques, G; Keller, M; Mondorf, AW; Prüfer, D; Weise, M, 1981) |
| "Aspirin ingestion was documented by multiple, random, unannounced blood salicylate levels." | 1.26 | Aspirin and analgesic nephropathy. ( Emkey, RD; Mills, JA, 1982) |
| "Rats treated with indomethacin showed a marked decrease of proteinuria (tested by the 3% sulfosalicylic aicd method) and a clear ultrastructural picture of hyperplasia and hypertrophy of podocytes." | 1.26 | Indomethacin and lysine acetylsalicylate in rats with autologous nephrotoxic serum nephritis. Biochemical and morphological studies. ( Cioffi, A; Conte, F; Di Belgiojoso, GB; Donati, MB; Saruggia, M; Sessa, A, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 32 (44.44) | 18.7374 |
| 1990's | 11 (15.28) | 18.2507 |
| 2000's | 15 (20.83) | 29.6817 |
| 2010's | 8 (11.11) | 24.3611 |
| 2020's | 6 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Silva, JBNF | 1 |
| Calcia, TBB | 1 |
| Silva, CP | 1 |
| Guilherme, RF | 1 |
| Almeida-Souza, F | 1 |
| Lemos, FS | 1 |
| Calabrese, KS | 1 |
| Caruso-Neves, C | 1 |
| Neves, JS | 1 |
| Benjamim, CF | 1 |
| Chen, D | 2 |
| Yang, S | 3 |
| Ding, J | 2 |
| Liu, A | 1 |
| Zhang, J | 1 |
| Zhang, Y | 1 |
| Song, L | 2 |
| Ju, Y | 1 |
| Feng, Y | 1 |
| Yang, Y | 1 |
| Hou, X | 1 |
| Zhang, X | 1 |
| Zhu, X | 1 |
| Wang, Y | 1 |
| Yang, M | 1 |
| Soejima, H | 1 |
| Ogawa, H | 1 |
| Morimoto, T | 1 |
| Okada, S | 1 |
| Matsumoto, C | 1 |
| Nakayama, M | 1 |
| Masuda, I | 1 |
| Jinnouchi, H | 1 |
| Waki, M | 1 |
| Saito, Y | 1 |
| Scott, G | 1 |
| Gillon, TE | 1 |
| Pels, A | 1 |
| von Dadelszen, P | 2 |
| Magee, LA | 2 |
| Chung, EYM | 1 |
| Tiku, A | 1 |
| Seeho, S | 1 |
| Mather, A | 1 |
| Shi, X | 1 |
| Zhao, N | 1 |
| Ma, Y | 1 |
| Hui, D | 1 |
| Hladunewich, MA | 1 |
| Peeters, MJ | 1 |
| van Zuilen, AD | 1 |
| van den Brand, JA | 1 |
| Bots, ML | 1 |
| van Buren, M | 1 |
| Ten Dam, MA | 1 |
| Kaasjager, KA | 1 |
| Ligtenberg, G | 1 |
| Sijpkens, YW | 1 |
| Sluiter, HE | 1 |
| van de Ven, PJ | 1 |
| Vervoort, G | 1 |
| Vleming, LJ | 1 |
| Blankestijn, PJ | 1 |
| Wetzels, JF | 1 |
| Liu, M | 1 |
| Li, XC | 1 |
| Lu, L | 1 |
| Cao, Y | 1 |
| Sun, RR | 1 |
| Chen, S | 1 |
| Zhang, PY | 1 |
| Davila, CD | 1 |
| Vargas, F | 1 |
| Huang, KH | 1 |
| Monaco, T | 1 |
| Dimou, A | 1 |
| Rangaswami, J | 1 |
| Figueredo, VM | 1 |
| Koren, G | 1 |
| Sakariassen, KS | 1 |
| Alberts, P | 1 |
| Fontana, P | 1 |
| Mann, J | 1 |
| Bounameaux, H | 1 |
| Sorensen, AS | 1 |
| Ge, FJ | 1 |
| Xu, JM | 1 |
| Harmankaya, O | 1 |
| Baştürk, T | 1 |
| Oztürk, Y | 1 |
| Karabiber, N | 1 |
| Obek, A | 1 |
| RAMSAY, AG | 1 |
| WHITE, DF | 1 |
| Kawasaki, Y | 1 |
| Hosoya, M | 1 |
| Takahashi, A | 1 |
| Isome, M | 1 |
| Tanji, M | 1 |
| Suzuki, H | 1 |
| Xu, S | 1 |
| Jiang, B | 1 |
| Maitland, KA | 1 |
| Bayat, H | 1 |
| Gu, J | 1 |
| Nadler, JL | 1 |
| Corda, S | 1 |
| Lavielle, G | 1 |
| Verbeuren, TJ | 1 |
| Zuccollo, A | 1 |
| Cohen, RA | 1 |
| Garcia-Donaire, JA | 1 |
| Ruilope, LM | 1 |
| Shin, JI | 1 |
| Lee, JS | 1 |
| Camargo, EG | 1 |
| Weinert, LS | 1 |
| Lavinsky, J | 1 |
| Gross, JL | 1 |
| Silveiro, SP | 1 |
| Shekelle, P | 1 |
| Vijan, S | 1 |
| Sinsakul, M | 1 |
| Sika, M | 1 |
| Rodby, R | 1 |
| Middleton, J | 1 |
| Shyr, Y | 1 |
| Chen, H | 1 |
| Han, E | 1 |
| Lehrich, R | 1 |
| Clyne, S | 1 |
| Schulman, G | 1 |
| Harris, R | 1 |
| Lewis, J | 1 |
| Weise, M | 1 |
| Prüfer, D | 1 |
| Jaques, G | 1 |
| Keller, M | 1 |
| Mondorf, AW | 1 |
| Garin, EH | 1 |
| Richard, GA | 1 |
| Ogawa, S | 1 |
| Naruse, T | 1 |
| Aul, C | 1 |
| Scharf, RE | 1 |
| Königshausen, T | 1 |
| Küppers, H | 1 |
| Grabensee, B | 1 |
| Emkey, RD | 1 |
| Mills, JA | 1 |
| Kurokawa, H | 1 |
| Sakamoto, K | 1 |
| Rasmussen, S | 1 |
| Petersen, J | 1 |
| Nielsen, IL | 1 |
| Christensen, P | 1 |
| Hilden, T | 1 |
| Tunbridge, RD | 1 |
| Zäuner, I | 1 |
| Böhler, J | 1 |
| Braun, N | 1 |
| Grupp, C | 1 |
| Heering, P | 1 |
| Schollmeyer, P | 1 |
| De Cosmo, S | 1 |
| Earle, K | 1 |
| Morocutti, A | 1 |
| Walker, J | 1 |
| Ruggenenti, P | 1 |
| Remuzzi, G | 2 |
| Viberti, GC | 1 |
| Faas, MM | 1 |
| Schuiling, GA | 1 |
| Baller, JF | 1 |
| Valkhof, N | 1 |
| Bakker, WW | 1 |
| Sibai, BM | 1 |
| Caritis, S | 2 |
| Hauth, J | 1 |
| Lindheimer, M | 1 |
| VanDorsten, JP | 2 |
| MacPherson, C | 2 |
| Klebanoff, M | 2 |
| Landon, M | 2 |
| Miodovnik, M | 2 |
| Paul, R | 2 |
| Meis, P | 2 |
| Dombrowski, M | 1 |
| Thurnau, G | 2 |
| Roberts, J | 1 |
| McNellis, D | 1 |
| Branch, DW | 1 |
| Porter, TF | 1 |
| Rittenhouse, L | 1 |
| Sibai, B | 1 |
| Hogg, B | 1 |
| Lindheimer, MD | 1 |
| Zaman, Z | 1 |
| Roggeman, S | 1 |
| Cappelletti, P | 1 |
| Ferrai, G | 1 |
| Buxeda, M | 1 |
| Barba, N | 1 |
| Makino, H | 1 |
| Tanaka, I | 1 |
| Mukoyama, M | 1 |
| Sugawara, A | 1 |
| Mori, K | 1 |
| Muro, S | 1 |
| Suganami, T | 1 |
| Yahata, K | 1 |
| Ishibashi, R | 1 |
| Ohuchida, S | 1 |
| Maruyama, T | 1 |
| Narumiya, S | 1 |
| Nakao, K | 1 |
| Kupor, LR | 1 |
| Lowance, DC | 1 |
| McPhaul, JJ | 1 |
| Hormaechea, E | 1 |
| Carlson, RW | 1 |
| Rogove, H | 1 |
| Uphold, J | 1 |
| Henning, RJ | 1 |
| Weil, MH | 1 |
| Sessa, A | 1 |
| Cioffi, A | 1 |
| Conte, F | 1 |
| Saruggia, M | 1 |
| Di Belgiojoso, GB | 1 |
| Donati, MB | 1 |
| Sternberg, M | 1 |
| Peyroux, J | 1 |
| Grochulski, A | 1 |
| Engler, R | 1 |
| Feret, J | 1 |
| Moisy, M | 1 |
| Lagrue, G | 1 |
| Jayle, MF | 1 |
| De La Cruz, JP | 1 |
| Cámara, S | 1 |
| Frutos, MA | 1 |
| Sánchez De La Cuesta, F | 1 |
| Gordge, MP | 1 |
| Rylance, PB | 1 |
| Neild, GH | 1 |
| Uzan, S | 1 |
| Beaufils, M | 1 |
| Breart, G | 1 |
| Bazin, B | 1 |
| Capitant, C | 1 |
| Paris, J | 1 |
| Knotková, V | 2 |
| Petrů, I | 2 |
| Nĕmecek, K | 2 |
| Jáchymová, M | 2 |
| Szer, IS | 1 |
| Goldenstein-Schainberg, C | 1 |
| Kurtin, PS | 1 |
| McParland, P | 1 |
| Pearce, JM | 1 |
| Chamberlain, GV | 1 |
| Hopper, AH | 1 |
| Tindall, H | 1 |
| Davies, JA | 1 |
| Zoja, C | 1 |
| Benigni, A | 1 |
| Livio, M | 1 |
| Bergamelli, A | 1 |
| Orisio, S | 1 |
| Abbate, M | 1 |
| Bertani, T | 1 |
| Hachicha, J | 1 |
| Ammous, A | 1 |
| Damak, J | 1 |
| Hammami, M | 1 |
| Ghorbel, A | 1 |
| Rekik, S | 1 |
| Jarraya, A | 1 |
| Ehrich, JH | 1 |
| Wurster, U | 1 |
| Lütge, M | 1 |
| Doehring, E | 1 |
| Oemar, B | 1 |
| Donadio, JV | 1 |
| Ilstrup, DM | 1 |
| Holley, KE | 1 |
| Romero, JC | 1 |
| Husted, SE | 1 |
| Nielsen, HK | 1 |
| Petersen, T | 1 |
| Mogensen, CE | 1 |
| Geday, E | 1 |
| Bang, NU | 1 |
| Trygstad, W | 1 |
| Schroeder, JE | 1 |
| Heidenreich, RO | 1 |
| Csiscko, BM | 1 |
| Bailey, RR | 1 |
| Neale, TJ | 1 |
| Little, PJ | 1 |
| Zachariae, E | 1 |
| Sylvest, J | 1 |
| George, CR | 1 |
| Slichter, SJ | 1 |
| Quadracci, LJ | 1 |
| Striker, GE | 1 |
| Harker, LA | 1 |
| Rosenmann, E | 1 |
| Dishon, T | 1 |
| Boss, JH | 1 |
| Harrison, JF | 1 |
| Parker, RW | 1 |
| De Silva, KL | 1 |
| Burry, HC | 1 |
| Macklon, AF | 1 |
| Craft, AW | 1 |
| Thompson, M | 1 |
| Kerr, DN | 1 |
| Snapper, I | 1 |
| van Ormondt Tillema, A | 1 |
| Diamond, I | 1 |
| Seld, D | 1 |
| Kwaan, HC | 1 |
| Colwell, JA | 1 |
| Cruz, S | 1 |
| Suwanwela, N | 1 |
| Dobbie, JG | 1 |
| Clarkson, AR | 1 |
| MacDonald, MK | 1 |
| Cash, JD | 1 |
| Robson, JS | 1 |
| Randall, RE | 1 |
| Stacy, WK | 1 |
| Toone, EC | 1 |
| Prout, GR | 1 |
| Madge, GE | 1 |
| Shadomy, HJ | 1 |
| Shadomy, S | 1 |
| Utz, JP | 1 |
| Wajcner, G | 1 |
| Guedon, J | 1 |
| Chapman, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Synbiotics Supplementation on the Concentration of the Uremic Toxin Indoxyl Sulfate, Symptoms of Constipation, and Constipation-related Quality of Life in End-stage Renal Disease Patients Undergoing Hemodialysis[NCT04527640] | 60 participants (Anticipated) | Interventional | 2020-09-15 | Not yet recruiting | |||
| [NCT00065559] | 30 participants | Interventional | 2003-04-30 | Terminated | |||
| Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial[NCT04855513] | 414 participants (Anticipated) | Interventional | 2022-03-24 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 reviews available for aspirin and Proteinuria
| Article | Year |
|---|---|
Guidelines-similarities and dissimilarities: a systematic review of international clinical practice guidelines for pregnancy hypertension.
Topics: Anticonvulsants; Antihypertensive Agents; Aspirin; Calcium; Delivery, Obstetric; Female; Glucocortic | 2022 |
Chronic Kidney Disease and Pregnancy.
Topics: Aspirin; Female; Glomerular Filtration Rate; Humans; Hypertension, Pregnancy-Induced; Infant, Newbor | 2019 |
Cardiovascular disease and its relationship with chronic kidney disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aspirin; Blood Pressure; Cardiovascular Diseases; | 2014 |
Preventing deaths due to the hypertensive disorders of pregnancy.
Topics: Aspirin; Birth Intervals; Calcium; Cardiotocography; Dietary Supplements; Eclampsia; Female; Food Su | 2016 |
Effect of pharmaceutical interventions targeting thromboxane receptors and thromboxane synthase in cardiovascular and renal diseases.
Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Humans; | 2009 |
[Generation mechanisms and management strategies of adverse reactions to Bevacizumab during cancer treatment].
Topics: Angiogenesis Inhibitors; Angiotensin-Converting Enzyme Inhibitors; Antibodies, Monoclonal; Antibodie | 2010 |
Spotlight on renin: cardiovascular outcomes in chronic kidney disease and suppression of the renin-angiotensin system.
Topics: Albuminuria; Aspirin; Cardiovascular Diseases; Chronic Disease; Glomerular Filtration Rate; Humans; | 2006 |
Quality indicators for the care of diabetes mellitus in vulnerable elders.
Topics: Aged; Aspirin; Diabetes Complications; Diabetes Mellitus; Evidence-Based Medicine; Frail Elderly; Gl | 2007 |
The management of pregnancy in hypertensive patients.
Topics: Adult; Antihypertensive Agents; Aspirin; Blood Pressure; Congenital Abnormalities; Female; Humans; H | 1994 |
12 trials available for aspirin and Proteinuria
| Article | Year |
|---|---|
Proteinuria is independently associated with the incidence of primary cardiovascular events in diabetic patients.
Topics: Aged; Aspirin; Cardiovascular Diseases; Diabetes Mellitus; Female; Fibrinolytic Agents; Humans; Inci | 2020 |
Nurse practitioner care improves renal outcome in patients with CKD.
Topics: Aged; Ambulatory Care Facilities; Antihypertensive Agents; Aspirin; Biomarkers; Cholesterol, LDL; Cr | 2014 |
The effect of aspirin on the antiproteinuric properties of enalapril in microalbuminuric type 2 diabetic patients: a randomized, double-blind, placebo-controlled study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cardiovascular Agents; Cross-Over Studies; | 2007 |
A randomized trial of a 6-week course of celecoxib on proteinuria in diabetic kidney disease.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Celecoxib; Creatinine; Cross-Over Studies; | 2007 |
Effect of aspirin and dipyridamole on proteinuria in idiopathic membranoproliferative glomerulonephritis: a multicentre prospective clinical trial. Collaborative Glomerulonephritis Therapy Study Group (CGTS)
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Aspirin; Blood Pressure; Dietary Proteins; | 1994 |
Glucose-induced changes in renal haemodynamics in proteinuric type 1 (insulin-dependent) diabetic patients: inhibition by acetylsalicilic acid infusion.
Topics: Adult; Analysis of Variance; Aspirin; Biopsy; Blood Proteins; Diabetes Mellitus, Type 1; Diabetic Ne | 1993 |
Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.
Topics: Aspirin; Birth Weight; Blood Pressure; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; | 2000 |
Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial.
Topics: Adult; Aspirin; Birth Weight; Dipyridamole; Double-Blind Method; Drug Administration Schedule; Drug | 1991 |
Doppler ultrasound and aspirin in recognition and prevention of pregnancy-induced hypertension.
Topics: Administration, Oral; Adult; Aspirin; Blood Platelets; Drug Administration Schedule; Drug Evaluation | 1990 |
Administration of aspirin-dipyridamole reduces proteinuria in diabetic nephropathy.
Topics: Adult; Aspirin; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dipyridamole; Double-Blind Method | 1989 |
Osteoarthritis of the knee treated with tolfenamic acid.
Topics: Adult; Aged; Alanine Transaminase; Aspirin; Body Weight; Clinical Trials as Topic; Creatinine; Femal | 1972 |
Modification by drugs of urinary fibrin/fibrinogen degradation products in glomerulonephritis.
Topics: Adolescent; Adult; Aged; Aspirin; Child; Creatinine; Female; Fibrin; Fibrinogen; Glomerulonephritis; | 1972 |
51 other studies available for aspirin and Proteinuria
| Article | Year |
|---|---|
ATRvD1 Attenuates Renal Tubulointerstitial Injury Induced by Albumin Overload in Sepsis-Surviving Mice.
Topics: Acute Kidney Injury; Albumins; Animals; Aspirin; Biomarkers; Cytokines; Disease Models, Animal; Doco | 2021 |
Natural Flavonoid Quercetin Enhances the Anti-inflammatory Effects of Aspirin in a Preeclampsia-like Rat Model Induced by Lipopolysaccharide.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Disease Models, Animal; Female; Flavonoids; Humans; Lipo | 2023 |
Quercetin Supplement to Aspirin Attenuates Lipopolysaccharide-Induced Pre-eclampsia-Like Impairments in Rats Through the NLRP3 Inflammasome.
Topics: Animals; Aspirin; Caspase 1; Dietary Supplements; Female; Humans; Inflammasomes; Lipopolysaccharides | 2022 |
Combining curcumin and aspirin ameliorates preeclampsia-like symptoms by inhibiting the placental TLR4/NF-κB signaling pathway in rats.
Topics: Animals; Aspirin; Curcumin; Female; Humans; NF-kappa B; Placenta; Placenta Growth Factor; Pre-Eclamp | 2023 |
Significant infrarenal aortic stenosis in pregnancy: a case report.
Topics: Adult; Aortic Valve Stenosis; Aspirin; Calcium; Calcium-Regulating Hormones and Agents; Cesarean Sec | 2019 |
Ameliorative effects of pre-eclampsia by quercetin supplement to aspirin in a rat model induced by L-NAME.
Topics: Animals; Aspirin; Blood Pressure; Cytokines; Dietary Supplements; Disease Models, Animal; Female; In | 2019 |
Dipstick proteinuria is an independent predictor of high on treatment platelet reactivity in patients on clopidogrel, but not aspirin, admitted for major adverse cardiovascular events.
Topics: Aged; Aged, 80 and over; Aspirin; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Cohort Stud | 2015 |
Hearing loss in a woman on aspirin: the silent pharmacokinetic parameter.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Disease Progression; Female; Hearing Loss; | 2009 |
Effect of acetylsalicylic acid and dipyridamole in primary membranoproliferative glomerulonephritis type I.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Creatinine; Dipyridamole; Drug | 2001 |
PHENACETIN NEPHROPATHY.
Topics: Acidosis; Animals; Aspirin; Bacteriuria; Biological Transport; Caffeine; Codeine; Dogs; Drug Therapy | 1965 |
Consensus statement for the prevention of vascular disease.
Topics: Aged; Aspirin; Atrial Fibrillation; Australia; Diabetes Complications; Diabetes Mellitus; Family Pra | 2004 |
Myeloid-related protein 8 expression on macrophages is a useful prognostic marker for renal dysfunction in children with MPGN type 1.
Topics: Adolescent; Aspirin; Biomarkers; Biopsy; Calgranulin A; Calgranulin B; Child; Creatinine; Cyclophosp | 2005 |
The thromboxane receptor antagonist S18886 attenuates renal oxidant stress and proteinuria in diabetic apolipoprotein E-deficient mice.
Topics: Animals; Apolipoproteins E; Arachidonate 12-Lipoxygenase; Aspirin; Diabetes Mellitus, Experimental; | 2006 |
Can chronic fatigue symptoms associated with nutcracker phenomenon be treated with aspirin?
Topics: Adolescent; Angioplasty, Balloon; Aorta; Aspirin; Child; Child, Preschool; Fatigue; Fatigue Syndrome | 2007 |
Beta 2-microglobulin and other proteins as parameter for tubular function.
Topics: Acetaminophen; Amino Acid Sequence; Aspirin; beta 2-Microglobulin; Beta-Globulins; Female; Graft Rej | 1981 |
Prostaglandin synthesis inhibitors and primary antibody response in experimental nephrotic syndrome.
Topics: Animals; Antibody-Producing Cells; Aspirin; Hemolytic Plaque Technique; Indomethacin; Isoantibodies; | 1984 |
Effects of various antiplatelet drugs and defibrinating agent on experimental glomerulonephritis in rats.
Topics: Animals; Anticoagulants; Aspirin; Batroxobin; Blood Platelets; Dipyridamole; Glomerulonephritis; Imm | 1982 |
[Differential therapy of thrombotic-thrombopenic purpura. Administration of fresh plasma versus plasma separation].
Topics: Acute Kidney Injury; Adult; Aspirin; Blood Platelets; Blood Transfusion; Dipyridamole; Erythrocytes; | 1984 |
Aspirin and analgesic nephropathy.
Topics: Adult; Aged; Arthritis, Rheumatoid; Aspirin; Creatinine; Female; History, 17th Century; Humans; Kidn | 1982 |
Effects of aspirin, prednisolone and indomethacin on nephrotoxic serum nephritis in the rat.
Topics: Animals; Aspirin; Indomethacin; Kidney; Kidney Function Tests; Male; Nephritis; Prednisolone; Protei | 1982 |
Effect of acetylsalicylic acid on renal function in systemic lupus erythematosus.
Topics: Adult; Aged; Aspirin; Creatinine; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Functio | 1982 |
Aspirin treatment of the low-dose-endotoxin-treated pregnant rat: pathophysiologic and immunohistologic aspects.
Topics: Albuminuria; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apyrase; Aspirin; Blood Pressure; Cel | 1997 |
Antiphospholipid antibodies in women at risk for preeclampsia.
Topics: Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Aspirin; Blood Pressure; Enzyme-Li | 2001 |
Evaluation of Aution Max AX-4280 automated urine test-strip analyser.
Topics: Ascorbic Acid; Aspirin; Chemistry, Clinical; Glucose; Hematuria; Humans; Hydrogen-Ion Concentration; | 2001 |
Prevention of diabetic nephropathy in rats by prostaglandin E receptor EP1-selective antagonist.
Topics: Animals; Aspirin; Autocrine Communication; Cells, Cultured; Cinnamates; Cyclooxygenase Inhibitors; D | 2002 |
Single and multiple drug therapy in autologous immune complex nephritis in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Azathioprine; Basement Membrane; Compleme | 1976 |
Hypovolemia, pulmonary edema and protein changes in severe salicylate poisoning.
Topics: Adult; Aspirin; Blood Pressure; Blood Proteins; Blood Volume; Female; Hematocrit; Humans; Hypoprotei | 1979 |
Indomethacin and lysine acetylsalicylate in rats with autologous nephrotoxic serum nephritis. Biochemical and morphological studies.
Topics: Animals; Aspirin; Basement Membrane; Disease Models, Animal; Female; Glomerulonephritis; Immune Sera | 1978 |
Biochemical criteria for the evaluation of drug efficiency on adjuvant arthritis and nephrotoxic serum nephritis in the rat: studies with phenylbutazone, L-Asparaginase, colchicine, lysine acetylsalicylate, and pyridinol carbamate.
Topics: Animals; Arthritis, Rheumatoid; Asparaginase; Aspirin; Basement Membrane; Blood Proteins; Carbamates | 1975 |
Effect of dipyridamole with or without aspirin on urine protein excretion in patients with membranous glomerulonephritis.
Topics: Adult; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Hum | 1992 |
Anti-platelet therapy in diabetic and non-diabetic progressive renal failure.
Topics: Aspirin; Blood Pressure; Creatinine; Diabetic Nephropathies; Dipyridamole; Docosahexaenoic Acids; Dr | 1992 |
[The effect of decreased thromboxane synthesis on proliferative glomerulonephritis].
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aspirin; Chronic Disease; Creatinine; Female; Glomerular Filtra | 1991 |
Paucity of renal complications associated with nonsteroidal antiinflammatory drugs in children with chronic arthritis.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Aspirin; Child; Child, Pre | 1991 |
[The effect of acetylsalicylic acid and dipyridamole on glomerular filtration and proteinuria in chronic glomerulonephritis].
Topics: Adult; Aspirin; Chronic Disease; Dipyridamole; Female; Glomerular Filtration Rate; Glomerulonephriti | 1990 |
Selective inhibition of platelet thromboxane generation with low-dose aspirin does not protect rats with reduced renal mass from the development of progressive disease.
Topics: Animals; Aspirin; Blood Platelets; Kidney; Kidney Diseases; Kidney Glomerulus; Male; Platelet Aggreg | 1989 |
[Prevention of complications of severe arterial hypertension in pregnancy using platelet antiaggregants].
Topics: Adult; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Humans; Hypertension; Pregnancy; Pr | 1989 |
[Enzymuria and kidney diseases in childhood].
Topics: Acetylglucosaminidase; Adolescent; Aminopeptidases; Anti-Bacterial Agents; Aspirin; CD13 Antigens; C | 1986 |
Platelet-inhibitor treatment of diabetic nephropathy: a 10-year prospective study.
Topics: Adult; Aspirin; Blood Platelets; Cell Survival; Creatinine; Diabetic Nephropathies; Dipyridamole; Dr | 1988 |
Acute effects of acetylsalicylic acid on renal and hepatic function in normal humans.
Topics: Adolescent; Adult; Alanine Transaminase; Albuminuria; Aspartate Aminotransferases; Aspirin; beta 2-M | 1985 |
Enhanced platelet function in glomerular renal disease.
Topics: Adenosine Diphosphate; Adolescent; Aspirin; Beta-Globulins; Blood Cell Count; Blood Platelets; Child | 1973 |
Analgesic nephropathy.
Topics: Adult; Aged; Analgesics; Anemia; Aspirin; Codeine; Drug Combinations; Female; Follow-Up Studies; Hum | 1974 |
A kinetic evaluation of hemostasis in renal disease.
Topics: Aspirin; Blood Coagulation; Complement System Proteins; Diabetic Nephropathies; Dipyridamole; Fibrin | 1974 |
Urinary excretion of kidney antigens in rats consuming analgesics.
Topics: Animals; Antigens; Aspirin; Diet; Female; Immune Sera; Immunodiffusion; Kidney Diseases; Kidney Tubu | 1972 |
Lysozymuria and acute disorders of renal function.
Topics: Acetaminophen; Acute Disease; Aspirin; Electroshock; Glomerulonephritis; Heart Failure; Humans; Hypo | 1973 |
Drug-induced nephropathies.
Topics: Animals; Arthritis, Rheumatoid; Aspirin; Colic; Complement System Proteins; Glomerular Filtration Ra | 1973 |
Editorial: Analgesic nephropathy or phenacetin poisoning.
Topics: Animals; Aspirin; Humans; Kidney Failure, Chronic; Phenacetin; Proteinuria; Rats; Substance-Related | 1974 |
Aspirin and analgesic nephropathy.
Topics: Adult; Aged; Arthritis, Rheumatoid; Aspirin; Blood Pressure; Creatinine; Female; Humans; Kidney Dise | 1974 |
On the heterogeneity of Bence Jones protein.
Topics: Acrylates; Antigens; Aspirin; Bence Jones Protein; Chemical Precipitation; Electrophoresis; Gels; Hu | 1969 |
Increased platelet aggregation in diabetes mellitus.
Topics: Adenosine Diphosphate; Aspirin; Blood Chemical Analysis; Blood Proteins; Creatinine; Diabetes Mellit | 1972 |
Cryptococcal pyelonephritis.
Topics: Adrenal Cortex Hormones; Adult; Aged; Amphotericin B; Arthritis, Rheumatoid; Aspirin; Cryptococcosis | 1968 |
[Acute anuric renal insufficiency with necrosing arteriolitis. Etiologic problems].
Topics: Acute Kidney Injury; Adult; Anemia, Hemolytic; Angioedema; Anuria; Arteritis; Arthritis; Aspirin; Dr | 1968 |